ABx's ALCORE achieves >90% fluorine recovery in latest test runs
TechInvest
by
4d ago
ABx Group (ASX: ABX) has revealed that the latest round of independent analysis of samples from further runs of its 83%-owned subsidiary ALCORE’s bath pilot batch reactor with subsequent further ..read more
Visit website
LGP sends first Polish cannabis flower shipment
TechInvest Magazine
by
2M ago
Little Green Pharma Ltd (ASX: LGP) has shipped its first batch of LGP- branded high-THC Desert Flame cannabis flower products to Poland ..read more
Visit website
Proteomics granted European patent for OxiDx technology
TechInvest Magazine
by
2M ago
Predictive diagnostics pioneer Proteomics International Laboratories’ (ASX: PIQ) subsidiary OxiDx Pty Ltd has been granted a patent in 19 major European countries for its platform technology to ..read more
Visit website
Memphasys’ Felix System sales orders accelerate in Japan
TechInvest Magazine
by
2M ago
ABx Group Limited (ASX:ABX) has appointed highly experienced director Joycelyn Morton as an independent non- executive director, as well as 83%-owned subsidiary ALCORE ..read more
Visit website
ABX Group adds experienced director Joycelyn Morton to its board
TechInvest Magazine
by
2M ago
ABx Group Limited (ASX:ABX) has appointed highly experienced director Joycelyn Morton as an independent non- executive director, as well as 83%-owned subsidiary ALCORE ..read more
Visit website
QEM produce first Vanadium Pentoxide from industrial waste
TechInvest Magazine
by
3M ago
QEM Limited (ASX: QEM) has partnered with The University of Queensland to produce the first high purity vanadium pentoxide (V2O5) from an industrial waste stream in Australia. V2O5 is the essential ..read more
Visit website
LGP welcomes German decision to legalise cannabis
TechInvest Magazine
by
3M ago
Little Green Pharma (ASX: LGP) has welcomed historic move of the German Bundestag to vote to legalise cannabis by removing it from the Narcotics List from 1 April 2024. This represents the most ..read more
Visit website
LGP welcomes start-up of Reset sponsored WA Psilocybin clinical trial
TechInvest Magazine
by Staff Writers
5M ago
Little Green Pharma Ltd’s (ASX: LGP) psychedelics focused subsidiary Reset Mind Sciences has launched its clinical trial into the efficacy and safety of psilocybin assisted therapy involving family members for patients with treatment resistant major depressive disorder. The clinical Trial, anticipated to take 12 months to complete, builds on the increasing body of research globally into the use of psilocybin to treat depressive related conditions by incorporating key family members into the preparatory and integration therapy sessions that precede and follow the psilocybin administration sess ..read more
Visit website
Lumos signs major development and IP agreements with US-based Hologic
TechInvest Magazine
by Staff Writers
5M ago
Rapid, point-of-care (POC) diagnostic technology developer Lumos Diagnostics Holdings (ASX:LDX) has signed two new agreements with US based women’s health company, Hologic, Inc. Hologic is a leading innovator and diagnostics service provider in women’s health and has engaged Lumos to develop a next generation version of one of Hologic’s leading on-market women’s health products. The two agreements encompass a Development Agreement and an Intellectual Property (IP) Agreement. Under the Development Agreement Lumos is entitled to receive up to US$4.7 million in payments over an 18-24 month timef ..read more
Visit website
AVITA Medical reaches exclusive distribution agreement
TechInvest Magazine
by Staff Writers
5M ago
Commercial-stage regenerative medicine company AVITA Medical (ASX: AVH) has entered into an exclusive multi-year distribution agreement with Stedical Scientific to commercialise PermeaDerm Biosynthetic Wound Matrix in the United States. PermeaDerm is cleared by the Food and Drug Administration as a transparent matrix for use in the treatment of a variety of wound types until healing is achieved. Under the terms of the agreement, AVITA Medical will hold the exclusive rights to market, sell, and distribute PermeaDerm products, including any future enhancements or modifications, within the Unite ..read more
Visit website

Follow TechInvest on FeedSpot

Continue with Google
Continue with Apple
OR